| 6:10 PM |
Key Message from the ADAPT-TAVR Trial: What We Learned? Lecturer: Duk-Woo Park
|
|---|---|
| 6:20 PM |
Next Target for Valve Pharmacology: Mechanical Valve Revisited with NOAC - RENOVATE Trial Lecturer: Joon Bum Kim
|
| 6:30 PM |
Long-Term Valve Durability Issues and Optimal Decision-Making: TAVR or SAVR, Mechanical or Bioprosthetic? Lecturer: Duk-Woo Park
|
| 6:40 PM | Q&A and Interactive Discussion |